Similar articles

• Cross-talk between Chk1 and Chk2 in double-mutant thymocytes.

  Zaugg K, Su YW, Reilly PT, Moolani Y, Cheung CC, Hakem R, Hirao A, Liu Q, Elledge SJ, Mak TW. Zaugg K, et al. Proc Natl Acad Sci U S A. 2007 Mar 6;104(10):3805-10. doi: 10.1073/pnas.0611584104. Epub 2007 Feb 26. Proc Natl Acad Sci U S A. 2007. PMID: 17360434 Free PMC article.
• Cooperative functions of Chk1 and Chk2 reduce tumour susceptibility in vivo.

  Niida H, Murata K, Shimada M, Ogawa K, Ohta K, Suzuki K, Fujigaki H, Khaw AK, Banerjee B, Hande MP, Miyamoto T, Miyoshi I, Shirai T, Motoyama N, Delhase M, Appella E, Nakanishi M. Niida H, et al. EMBO J. 2010 Oct 20;29(20):3558-70. doi: 10.1038/emboj.2010.218. Epub 2010 Sep 10. EMBO J. 2010. PMID: 20834228 Free PMC article.
• Chk1 and Chk2 are differentially involved in homologous recombination repair and cell cycle arrest in response to DNA double-strand breaks induced by camptothecins.

  Huang M, Miao ZH, Zhu H, Cai YJ, Lu W, Ding J. Huang M, et al. Mol Cancer Ther. 2008 Jun;7(6):1440-9. doi: 10.1158/1535-7163.MCT-07-2116. Mol Cancer Ther. 2008. PMID: 18566216
• The multiple checkpoint functions of CHK1 and CHK2 in maintenance of genome stability.

  Chen Y, Poon RY. Chen Y, et al. Front Biosci. 2008 May 1;13:5016-29. doi: 10.2741/3060. Front Biosci. 2008. PMID: 18508566 Review.
• The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer.

  Smith J, Tho LM, Xu N, Gillespie DA. Smith J, et al. Adv Cancer Res. 2010;108:73-112. doi: 10.1016/B978-0-12-380888-2.00003-0. Adv Cancer Res. 2010. PMID: 21034966 Review.